Nasus Pharma (NYSEAMERICAN:NSRX) Releases Earnings Results

Nasus Pharma (NYSEAMERICAN:NSRXGet Free Report) posted its earnings results on Monday. The company reported ($0.27) earnings per share for the quarter, FiscalAI reports.

Nasus Pharma Stock Performance

Shares of NSRX stock opened at $3.62 on Monday. Nasus Pharma has a twelve month low of $1.98 and a twelve month high of $9.99. The stock’s fifty day simple moving average is $3.19 and its 200 day simple moving average is $3.52.

Nasus Pharma Company Profile

(Get Free Report)

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.

Read More

Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.